482308-06-5

Basic information

• Product Name: ASISCHEM A93504
• Synonyms: 3-METHOXY-4-MORPHOLINOANILINE;ASISCHEM A93504;(3-methoxy-4-morpholino-phenyl)amine;3-methoxy-4-(4-morpholinyl)Benzenamine
• CAS NO: 482308-06-5
• Molecular Formula: C₁₁H₁₆N₂O₂
• Molecular Weight: 208.259
• Mol File: 482308-06-5.mol
• Article Data: 15

Chemical Properties

• Boiling Point: 411.054 °C at 760 mmHg
• Flash Point: 202.398 °C
• Appearance: /
• Density: 1.163 g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.573
• PKA: 7.56±0.40(Predicted)
• CAS DataBase Reference: ASISCHEM A93504(CAS DataBase Reference)
• NIST Chemistry Reference: ASISCHEM A93504(482308-06-5)
• EPA Substance Registry System: ASISCHEM A93504(482308-06-5)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 482308-06-5(Hazardous Substances Data)

Usage

General Description

ASISCHEM A93504 is a chemical compound with the molecular formula C13H12N2O4S, and the systematic name N-[(2S)-1-(2,5-dihydro-2-oxo-1H-pyrrol-1-yl)-2-oxoethyl]benzene-1-sulfonamide. It has a molecular weight of 296.31 g/mol. ASISCHEM A93504 is a sulfonylurea derivative, which is commonly used as a herbicide and pesticide. It works by inhibiting the enzyme acetolactate synthase, which is essential for the biosynthesis of branched-chain amino acids in plants, leading to their death. Additionally, ASISCHEM A93504 has potential applications in the pharmaceutical industry for the development of novel drugs due to its structural and functional properties. Overall, ASISCHEM A93504 is a versatile chemical with various industrial and research applications.

InChI:InChI=1/C11H16N2O2/c1-14-11-8-9(12)2-3-10(11)13-4-6-15-7-5-13/h2-3,8H,4-7,12H2,1H3

Upstream product

• 454-16-0 1-fluoro-2-methoxy-4-nitrobenzene 
• 77337-82-7 1-bromo-2-methoxy-4-nitrobenzene 
• 97459-72-8 4-(2-methoxy-4-nitrophenyl)morpholine 

Downstream Products

• 500544-48-9 C₂₄H₂₄N₆O₂ 
• 1610766-82-9 C₂₆H₃₃N₅O₅ 
• 1574541-74-4 (±)-3-bromo-1-(3-methoxy-4-morpholinophenyl)pyrrolidin-2-one 
• 1574538-36-5 3-(4-cyclopropylphenoxy)-1-(3-methoxy-4-morpholinophenyl)pyrrolidin-2-one 
• 1574538-37-6 3-(4-cyclopropylphenoxy)-1-(3-methoxy-4-morpholinophenyl)pyrrolidin-2-one 
• 1574538-35-4 (±)-3-(4-cyclopropylphenoxy)-1-(3-methoxy-4-morpholinophenyl)pyrrolidin-2-one 
• 1417795-37-9 C₁₆H₁₈IN₃O₂ 
• 1417795-25-5 C₂₄H₂₄N₄O₃ 
• 1417795-23-3 C₂₃H₂₂N₄O₂ 
• 1417795-30-2 C₂₄H₂₄N₄O₃ 
• 1417795-29-9 C₂₄H₂₄F₃N₃O₃ 
• 1417795-28-8 C₂₃H₂₄FN₃O₃ 
• 1417795-27-7 C₂₃H₂₄ClN₃O₃ 
• 1403818-58-5 3-(7-((3-methoxy-4-morpholinophenyl)amino)-1H-pyrazolo[4,3-d]pyrimidin-5-yl)benzenesulfonamide 

Relevant articles and documents

COMPOUNDS AND THEIR USES AS SPLEEN TYROSINE KINASE INHIBITORS

Provided are compounds of Formula (I) which can be used as Syk inhibitors and potently as therapeutic agents against diseases mediated by Syk.

QUINOLINE AND QUINAZOLINE COMPOUNDS AND METHODS OF USE THEREOF

Compounds and methods for their preparation and use as therapeutic or prophylactic agents, fo example for treatment of cancer, bacterial or viral diseases by targeting Ectonucleotide Pyrophosphatase/Phosphodiesterase- 1 (ENPP1).

VEGFR TYROSINE KINASE INHIBITORS

Novel compounds, their prodrugs, and the pharmaceutically acceptable salts as pharmaceutical compositions containing such compounds useful in treating certain diseases modulated by the inhibition of vascular endothelial growth factors (VEGFs) receptor tyrosine kinases are provided. In particular, compounds and compositions and the methods for the prophylaxis, management and treatment of cancers through the inhibition of VEGF receptor tyrosine kinases are provided.